| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.23 | 2e-06 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.23 | 2e-06 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-05 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.19 | 0.0007 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |